Why brain tumours are so difficult to treat
24 October, 2012
ISLAMABAD: Researchers have found that the most common and aggressive brain tumour grows by turning normal brain cells into stem cells, which can continuously replicate and regrow a tumour with only a handful of cells left behind.
The findings help explain why the tumours, called glioblastomas, are so difficult to treat, said study researcher Inder Verma, a molecular biologist at The Salk Institute in California.
Even the surgical removal of a tumour may not be able to extract every single cancerous cell, Verma told LiveScience.
Glioblastomas "reoccur because every cell that is left behind has the ability to start all over again," Verma said.
Glioblastoma multiforme tumours make up the majority of brain tumour cases and have a very poor prognosis. According to a 2010 study in CA: A Cancer Journal for Clinicians, the average survival rate after a glioblastoma diagnosis is 14 months (though improving surgical techniques had boosted that number from 10 months in only five years prior to the study).
Verma and his colleagues were interested in finding a more accurate way of studying tumour growth. Most mice studies of cancer introduce human tumour cells into mice with no immune systems or genetically engineer mice so that every cell is cancer-prone.
But that's not how tumours arise in real life, Verma said. He and his co-researchers wanted to find a way to mimic cancer's growth from a single cell to out-of-control.
Using viruses, they introduced cancer-causing genes into mice, developing a technique in which as few as 20 cancerous cells can trigger tumour growth. They then found that a mere 10 cells from one of these mouse tumours, transplanted into a healthy mouse, could lead to a whole new tumour in that mouse.
"That suggested that every cell in these tumours or glioblastomas has the ability to make new glioblastomas," Verma said.
Researchers once believed that glioblastomas arose only from glial cells, the "support" cells in the brain that surround neurons. When it was discovered that the brain contains stem cells, which are capable of transforming into any sort of neural tissue, researchers figured cancer could arise from those cells, too, said study researcher Dinorah Friedmann-Morvinski, also a Salk Institute researcher.
But now, Friedmann-Morvinski, Verma and their colleagues have found they can coax even neurons into cancer cells by introducing cancer-causing genes. The neurons, which should not be able to divide and reproduce anymore, turn back into stem cells, which can continuously divide.
Researchers have successfully reprogrammed cells into stem cells in the lab, a feat that earned scientists John B. Gurdon and Shinya Yamanaka the 2012 Nobel Prize in Medicine. It was surprising, still, to find the cancer cells performing this trick, Friedmann-Morvinski told LiveScience, but there were "some hints it might be happening."
The next step, the researchers said, is to learn more about how the cells revert into stem cells and then find a way to block the out-of-control growth of these cancerous cells.
"You have to kill them in order to kill the tumour in the long run," Verma said.
The researchers reported their results online in the journal Science.
End.
|
